Virtual Research & Development Day to review BA3071 CAB-CTLA-4 Phase 1 data in multiple solid tumor types to be held on December 13 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BCAB:
- BioAtla to Host Virtual R&D Day to Review BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types on Wednesday, December 13, 2023
- BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
- BioAtla presented Phase 2 trial data at IASLC 2023 on lung cancer
- BioAtla hosted a conference call
- BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
